Khosla Ventures Bets on Growing Human Tissues to Test New Therapies with Vivodyne Investment
Posted on 11/26/2023
Philadelphia-based Vivodyne is growing human tissues in the lab to test potential new therapies before they go to clinical trials. The company was founded in 2021 at the University of Pennsylvania by Bioengineering PhD Andrei Georgescu and Associate Professor of Bioengineering Dan Huh. Vivodyne’s platform was originally developed at Penn in the BIOLines Laboratory.
Vivodyne raised a total of US$ 38 million in a seed funding round. The round was led by Khosla Ventures and was joined by Kairos Ventures, CS Ventures, MBX Ventures, and Bison VC. In March 2021, Vivodyne raised US$ 4 million in seed funding from Kairos Ventures.
